BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1996093)

  • 1. Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax.
    Miura S; Ohtani K; Numata N; Niki M; Ohbo K; Ina Y; Gojobori T; Tanaka Y; Tozawa H; Nakamura M
    Mol Cell Biol; 1991 Mar; 11(3):1313-25. PubMed ID: 1996093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine synthesis and cellular inflammatory changes in lungs of mice bearing p40tax of human T-lymphotropic virus type 1.
    Miyazato A; Kawakami K; Iwakura Y; Saito A
    Clin Exp Immunol; 2000 Apr; 120(1):113-24. PubMed ID: 10759772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34.
    Baum PR; Gayle RB; Ramsdell F; Srinivasan S; Sorensen RA; Watson ML; Seldin MF; Baker E; Sutherland GR; Clifford KN
    EMBO J; 1994 Sep; 13(17):3992-4001. PubMed ID: 8076595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants in TNFSF4, TNFAIP3, TNIP1, BLK, SLC15A4 and UBE2L3 interact to confer risk of systemic lupus erythematosus in Chinese population.
    Zuo XB; Sheng YJ; Hu SJ; Gao JP; Li Y; Tang HY; Tang XF; Cheng H; Yin XY; Wen LL; Sun LD; Yang S; Cui Y; Zhang XJ
    Rheumatol Int; 2014 Apr; 34(4):459-64. PubMed ID: 24091983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of meningioma and common variation in genes related to innate immunity.
    Rajaraman P; Brenner AV; Neta G; Pfeiffer R; Wang SS; Yeager M; Thomas G; Fine HA; Linet MS; Rothman N; Chanock SJ; Inskip PD
    Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1356-61. PubMed ID: 20406964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system.
    Tan BJY; Sugata K; Ono M; Satou Y
    Front Immunol; 2022; 13():991928. PubMed ID: 36300109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The OX40/OX40L Axis Regulates T Follicular Helper Cell Differentiation: Implications for Autoimmune Diseases.
    Fu N; Xie F; Sun Z; Wang Q
    Front Immunol; 2021; 12():670637. PubMed ID: 34234777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform.
    Ylösmäki E; Ylösmäki L; Fusciello M; Martins B; Ahokas P; Cojoc H; Uoti A; Feola S; Kreutzman A; Ranki T; Karbach J; Viitala T; Priha P; Jäger E; Pesonen S; Cerullo V
    Mol Ther Oncolytics; 2021 Mar; 20():459-469. PubMed ID: 33718594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.
    Bojadzic D; Buchwald P
    Curr Top Med Chem; 2018; 18(8):674-699. PubMed ID: 29848279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crucial role of OX40/OX40L signaling in a murine model of asthma.
    Lei W; Zeng D; Liu G; Zhu Y; Wang J; Wu H; Jiang J; Huang J
    Mol Med Rep; 2018 Mar; 17(3):4213-4220. PubMed ID: 29344664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-cell leukemia virus type 1 (HTLV-1) Tax1 oncoprotein but not HTLV-2 Tax2 induces the expression of OX40 ligand by interacting with p52/p100 and RelB.
    Motai Y; Takahashi M; Takachi T; Higuchi M; Hara T; Mizuguchi M; Aoyagi Y; Terai S; Tanaka Y; Fujii M
    Virus Genes; 2016 Feb; 52(1):4-13. PubMed ID: 26739459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostimulation by OX40 Ligand Transgenic Ewing Sarcoma Cells.
    Reuter D; Staege MS; Kühnöl CD; Föll J
    Front Oncol; 2015; 5():242. PubMed ID: 26579494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells.
    Tanaka Y; Mizuguchi M; Takahashi Y; Fujii H; Tanaka R; Fukushima T; Tomoyose T; Ansari AA; Nakamura M
    Retrovirology; 2015 Jul; 12():56. PubMed ID: 26129803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF superfamily protein-protein interactions: feasibility of small- molecule modulation.
    Song Y; Buchwald P
    Curr Drug Targets; 2015; 16(4):393-408. PubMed ID: 25706111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural OX40L expressed on human T cell leukemia virus type-I-immortalized T cell lines interferes with infection of activated peripheral blood mononuclear cells by CCR5-utilizing human immunodeficiency virus.
    Kasahara D; Takara A; Takahashi Y; Kodama A; Tanaka R; Ansari AA; Tanaka Y
    Virol J; 2013 Nov; 10():338. PubMed ID: 24238037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
    Kinnear G; Wood KJ; Fallah-Arani F; Jones ND
    J Immunol; 2013 Aug; 191(3):1465-75. PubMed ID: 23817421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OX40 ligand expression abrogates the immunosuppressive function of retinal pigment epithelium.
    Cunningham MA; Li Z; Liu B; Yeh S; Nussenblatt RB
    J Ophthalmic Inflamm Infect; 2013 Jan; 3(1):12. PubMed ID: 23514269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface markers in HTLV-1 pathogenesis.
    Kress AK; Grassmann R; Fleckenstein B
    Viruses; 2011 Aug; 3(8):1439-59. PubMed ID: 21994790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.
    Kannian P; Green PL
    Viruses; 2010 Sep; 2(9):2037-2077. PubMed ID: 21994719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling through OX40 enhances antitumor immunity.
    Jensen SM; Maston LD; Gough MJ; Ruby CE; Redmond WL; Crittenden M; Li Y; Puri S; Poehlein CH; Morris N; Kovacsovics-Bankowski M; Moudgil T; Twitty C; Walker EB; Hu HM; Urba WJ; Weinberg AD; Curti B; Fox BA
    Semin Oncol; 2010 Oct; 37(5):524-32. PubMed ID: 21074068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.